Close Menu

SBIR grant

In addition to the federal grant, the startup has received $125,000 from a Michigan technology fund to help commercialize its GPU-based analysis platform.

The company will use the funds to develop and refine proprietary algorithms for identifying more complex variants including translocations and inversions. 

The firm will use the funds to advance its high-throughput single-cell analysis platform to analyze heterogeneity in cell populations for research and drug discovery.

Fueled by an NIH SBIR grant, analytics firm Cytobank is building out its machine-learning algorithms and adding pipelines to support big-picture research.

The firm plans to make the molecular testing system accessible to low-income countries, in part by reducing costs using reel-to-reel manufacturing.

The automated, whole-genome directional genomic hybridization system can measure de novo random, low-frequency, and complex structural variations.

As part of an NIH SBIR grant, Genomenon is automating the curation of medical literature in its Mastermind variant interpretation software.

The company said it will use the funding to accelerate the development of an affordable sequencing test for metagenomic samples.

The firm plans to integrate its technology with a compatible microfluidic sample prep method developed by researchers at Columbia University.

SolveBio is continuing development of a cloud-based genetic variation analysis and visualization system called Variant Explorer.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.